AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Clinical trial NCT00719550 · COMPLETED

Trial details

NCT number: NCT00719550
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophagogastric Junction Adenocarcinoma Gastric Cancer Esophageal Cancer

Start date: 2009-02-01
Primary completion: 2010-11-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.